| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/18/2010 | CN101809008A Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof |
| 08/18/2010 | CN101809005A Fused bicyclic compound |
| 08/18/2010 | CN101808668A Active targeting type polymeric micelle carrying drug enclosed therein and medicinal composition |
| 08/18/2010 | CN101808651A polymer conjugate of steroid |
| 08/18/2010 | CN101808646A Agent for improving motor complications or psychiatric symptoms in parkinson's disease |
| 08/18/2010 | CN101805337A Compound containing proline and isoxazole skeleton and preparation method and application thereof |
| 08/18/2010 | CN101805336A Compound containing tryptophane and isoxazole skeleton and preparation method and application thereof |
| 08/18/2010 | CN101805330A 2-alkyl-benzimidazole-1-acetyl hydrazone and synthesis method and application thereof |
| 08/18/2010 | CN101805325A Novel lignan compound and application thereof |
| 08/18/2010 | CN101805309A Benzamide derivatives useful as histone deacetylase inhibitors |
| 08/18/2010 | CN101804199A Pharmaceutical composition used for alimentary canals and application thereof |
| 08/18/2010 | CN101804093A Heat clearing antidote |
| 08/18/2010 | CN101152228B Genseng total sapnin micropore permeation pump, and its preparing method |
| 08/18/2010 | CN101024671B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 08/17/2010 | US7777069 Prodrugs of carbamate inhibitors of IMPDH |
| 08/17/2010 | US7777050 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 08/17/2010 | US7776921 Treating benign prostate hyperplasia with SARMS |
| 08/17/2010 | US7776919 modulators of the interaction between the receptor for advanced glycated end products; 3-(4-Benzyloxyphenyl)propionic Acid 2,4- Di-(3-Diethylamino-1-propoxy)aniline Amide; acute and chronic inflammation; diabetic late complications; Alzheimer's disease, erectile dysfunction; metastasis |
| 08/17/2010 | US7776908 Use in inhibiting PI-3-kinase activity in mammals; cancer; Acetic acid 4-diallylaminomethylene-6-hydroxy-1- alpha -methoxymeth-yl-10 beta ,13 beta -dimethyl-3,7,17-trioxo-1,3,4,7,10,11 beta , 12,13,14 alpha ,15,16,17-dodecahydro-2-oxa-cyclopenta[ alpha ]phenanthren-11-yl ester |
| 08/17/2010 | US7776902 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation |
| 08/17/2010 | US7776901 4-(6-spiro-1'-Cyclopropane-1a,6-dihydro-1H-cyclopropa[a]inden-6a-yl)-1H-imidazole, used for the treatment where the memory deficiency is associated with Alzheimer's disease and memory deficiency induced by scopolamine; side effect reduction |
| 08/17/2010 | US7776899 Mixture of phentolamine mesylate, papaverine hydrochloride and alprostadil with buffer; injecting into penis |
| 08/17/2010 | US7776898 Opioid receptor active compounds |
| 08/17/2010 | US7776895 Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases |
| 08/17/2010 | US7776890 1H-indazole compounds |
| 08/17/2010 | US7776879 anticholinergic agents such as Butylthiophen-2-ylmethylcarbamic acid 1-azabicyclo[2.2.2]oct-3-(R)yl ester, having a high affinity for muscarinic M3 receptors, useful for treating respiratory system, urogenital, gastrointestinal and cardiovascular disorders |
| 08/17/2010 | US7776853 Dietetics therapy; lipase inhibitor |
| 08/17/2010 | US7776829 lupus; for patients who are refractory or intractable to corticosteroid treatment, and treatment with cyclophosphamide, azathioprine, mycophenolate mofetil, anti-thymocyte-globin, methotrexate and immunoglobulin |
| 08/17/2010 | US7776820 Methods for decreasing risk of complications of prematurity using IGF-I and its analogs |
| 08/17/2010 | US7776552 Drug screening; for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 08/17/2010 | US7776354 Remedies for glomerular diseases |
| 08/17/2010 | US7776340 has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (eg Quebec and LY138) and human coronavirus strain OC43 |
| 08/17/2010 | US7776335 Microorganismal enzymatic polypeptide for use in developing vaccine for prevention and treatment of nesserial infection |
| 08/17/2010 | US7775469 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent |
| 08/17/2010 | CA2605854C Novel pyridine derivative and pyrimidine derivative (3) |
| 08/17/2010 | CA2557538C Benzimidazole derivative and use as an angiotensin ii receptor antagonist |
| 08/17/2010 | CA2527203C Casr antagonist |
| 08/17/2010 | CA2481535C Use of ep4 receptor ligands in the treatment of il-6 involved diseases |
| 08/17/2010 | CA2472372C Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors |
| 08/17/2010 | CA2471762C Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 08/17/2010 | CA2467065C Preparation for improving the action receptors to neurotransmitters and/or neuromodulators |
| 08/17/2010 | CA2461963C Cyclic amine compounds |
| 08/17/2010 | CA2444980C Single dose aromatase inhibitor for treating infertility |
| 08/17/2010 | CA2444867C Combination comprising n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent |
| 08/17/2010 | CA2431974C Urea and urethane derivatives as integrin inhibitors |
| 08/17/2010 | CA2425497C (n)-((s)-2-hydroxy-3-methyl-butyryl-1-(l-alaninyl)-(s)-1-amino-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepin-2-one dihydrate and its use in the treatment of alzheimer's disease |
| 08/17/2010 | CA2412854C Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
| 08/17/2010 | CA2411436C A method for detecting protein inhibitors and ligands |
| 08/17/2010 | CA2403086C Apoptosis inhibiting composition comprising a 15-keto-prostaglandin or derivative thereof |
| 08/17/2010 | CA2382940C 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands |
| 08/17/2010 | CA2370412C Pharmaceutical compounds |
| 08/17/2010 | CA2337828C Phosphinic and phosphonic acid derivatives used as pharmaceuticals |
| 08/17/2010 | CA2290742C Use of galt-2 inhibitor compounds to treat conditions associated with lactosylceramide |
| 08/17/2010 | CA2144527C Up-converting reporters for biological and other assays using laser excitation techniques |
| 08/12/2010 | WO2010090305A1 Substituted acylguanidine derivative |
| 08/12/2010 | WO2010090304A1 Acylguanidine derivative |
| 08/12/2010 | WO2010090300A1 Diazepinedione derivatives |
| 08/12/2010 | WO2010090272A1 Remedy for chronic inflammation and antibody to be used therein |
| 08/12/2010 | WO2010090200A1 Phenylimidazole compounds |
| 08/12/2010 | WO2010090009A1 Indoline derivatives |
| 08/12/2010 | WO2010089874A1 Ppar-γ-expression-enhancing agent, adiponectin-production-enhancing agent, ucp-activating agent, and pharmaceutical preparation, food or beverage comprising any one of the agents |
| 08/12/2010 | WO2010088735A1 Method of producing progenitor cells from differentiated cells |
| 08/12/2010 | US20100204329 Method of using and establishing an absorption rate level and a neuron firing level |
| 08/12/2010 | US20100204316 Pseudopolymorphic forms of a hiv protease inhibitor |
| 08/12/2010 | US20100204294 Methods For Assessing, Improving, Or Maintaining Urogenital Health in Postmenopausal Woman |
| 08/12/2010 | US20100204284 Hetero-substituted acetanilide derivatives as analgesic agents |
| 08/12/2010 | US20100204213 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 08/12/2010 | US20100204184 Phosphonates useful as modulators of T-gamma-9-delta-2 activity |
| 08/12/2010 | US20100204177 Process for preparing thermosensitive (poly(ethylene oxide) poly(propylene oxide)) derivates that can be used to functionalize chitosan |
| 08/12/2010 | US20100204101 Method and product for treatment and/or prevention of complications of prematurity |
| 08/12/2010 | US20100204087 Tribonectins |
| 08/12/2010 | US20100204086 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma |
| 08/12/2010 | US20100203633 Culture System for Rapid Expansion of Human Embryonic Stem Cells |
| 08/12/2010 | US20100203155 Segmented delivery system |
| 08/12/2010 | US20100203147 Viruses for the Treatment of Cellular Proliferative Disorders |
| 08/12/2010 | US20100203141 Stimuli-responsive low solubility hydrogel copolymers of n-isopropyl acrylamide and synthesis method |
| 08/12/2010 | US20100203138 Controlled Release Composition Comprising a Recombinant Gelatin |
| 08/12/2010 | US20100203124 Kappa-2 Carrageenan Composition and Products Made Therefrom |
| 08/12/2010 | US20100203119 Pharmaceutical treatment process using chitosan or derivative thereof |
| 08/12/2010 | US20100203116 Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo |
| 08/12/2010 | US20100203108 Patch and patch preparation |
| 08/12/2010 | US20100203086 Attack of tumor cells with missing, low or aberrant mhc expression by combining non mhc-restricted t-cells/nk-cells and mhc-restricted cells |
| 08/12/2010 | US20100203040 Genetic Products Which are Differentially Expressed in Tumors and Use Thereof |
| 08/12/2010 | US20100203027 Viral vector for gene therapy |
| 08/12/2010 | US20100202984 Naphthalene amidine imides |
| 08/12/2010 | US20100202983 Selectively targeted antimicrobials for the treatment of periodontal disease |
| 08/12/2010 | US20100202972 Use of gene variants of the human meis1, btbd9, map2k5, lbxcor1, ptprd or a2bp1 gene for diagnostic and therapeutic approaches to restless legs syndrome (rls) |
| 08/12/2010 | US20100202970 Intracellular reporters |
| 08/12/2010 | US20100202966 Implantable Sensor |
| 08/12/2010 | US20100202965 Annulus fibrosus detection in intervertebral discs using molecular imaging agents |
| 08/12/2010 | CA2751536A1 Indoline derivatives |
| 08/12/2010 | CA2750704A1 Phenylimidazole compounds |
| 08/12/2010 | CA2750559A1 Pharmaceutical formulations of tgf-.beta.1 inhibitor peptides |
| 08/11/2010 | EP2216409A1 Albumin fusion proteins |
| 08/11/2010 | EP2216343A1 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 08/11/2010 | EP2216330A1 Oxadiazolidinedione compound |
| 08/11/2010 | EP2216047A1 Regulator for signaling of toll-like receptor, which comprises cathepsin inhibitor as active ingredient |
| 08/11/2010 | EP2216043A1 Use of inductor agents gse24.2 for producing pharmaceutical compositions for treating illnesses relating to cellular senescence |
| 08/11/2010 | EP2216023A1 Condensed pyridine derivative and use thereof |
| 08/11/2010 | EP2216022A1 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors |